Zobrazeno 1 - 10
of 256
pro vyhledávání: '"Ebba Holme, Hansen"'
Publikováno v:
Cantarero-Arévalo, L, Andersen, A, Holstein, B E & Hansen, E H 2014, ' Migrant differences in adolescents’ medicine use for common health problems : A national representative survey ', Global Journal of Epidemiology and Public Health, vol. 1, no. 1, pp. 24-34 . https://doi.org/10.12974/2313-0946.2014.01.01.4
Aim: Despite the substantial proportion of adolescents use medicine for common health problems, prevalence of medicine use among adolescents with migrant background have rarely been documented, and the causal pathway continue to be poorly understood.
Autor:
Pernille Warrer, Peter Bjødstrup Jensen, Lise Aagaard, Lars Juhl Jensen, Søren Brunak, Malene Hammer Krag, Peter Rossing, Thomas Almdal, Henrik Ullits Andersen, Ebba Holme Hansen
Publikováno v:
Journal of Research in Pharmacy Practice, Vol 4, Iss 2, Pp 64-72 (2015)
Objective: Through manual review of clinical notes for patients with type 2 diabetes mellitus attending a Danish diabetes center, the aim of the study was to identify adverse drug reactions (ADRs) associated with three classes of glucose-lowering med
Externí odkaz:
https://doaj.org/article/a879d7ae208f40ecbd3642f40c2237a9
Autor:
Majken Linnemann Jensen, Marit Eika Jørgensen, Ebba Holme Hansen, Lise Aagaard, Bendix Carstensen
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0179546 (2017)
Poor adherence to medication therapy among type 2 diabetes patients is a clinical challenge. We aimed to determine which factors are associated with the three phases of long-term adherence to medication: initiation, implementation and discontinuation
Externí odkaz:
https://doaj.org/article/6a30704d2adc4642874ac69ebefc3ede
Autor:
Lise Aagaard, Ebba Holme Hansen
Publikováno v:
Journal of Research in Pharmacy Practice, Vol 2, Iss 1, Pp 44-49 (2013)
Objective: To characterize adverse drug reactions (ADRs) reported by European (EU) consumer for antineoplastic and immunomodulating medications. Methods: ADRs reported by consumers of antineoplastic and immunomodulating medications (anatomical thera
Externí odkaz:
https://doaj.org/article/279688245d894d4ca0fec76fa72b1502
Autor:
Lise Aagaard, Ebba Holme Hansen
Publikováno v:
Journal of Research in Pharmacy Practice, Vol 2, Iss 2, Pp 93-95 (2013)
Objective: To characterise consumer adverse drug reaction (ADR) reports for phosphodiesterase type 5 (PDE5) inhibitors. Methods: We included ADR reports submitted by adults to the European ADR database (EudraVigialnce) from 2007 to 2011. ADRs were c
Externí odkaz:
https://doaj.org/article/7e30d486e44a48c7b2046cba5caee8ea
Publikováno v:
Jacobsen, R, Ekholm, O, Rasmussen, N K, Hansen, E H & Frølich, A 2016, ' Socioeconomic Variations in Use of Prescription Medicines for COPD : A Register-Based Study ', Respiratory Care, vol. 61, no. 7, pp. 943-949 . https://doi.org/10.4187/respcare.04335
BACKGROUND: The purpose of this study was to examine socioeconomic variations in the use of prescription medicines among elderly subjects with COPD.METHODS: Data from the Danish national administrative registers were used. The study population includ
Autor:
Helle Wallach-Kildemoes, Ebba Holme Hansen, Kenneth Howse, Halfdan Petursson, Henrik Støvring
Publikováno v:
Journal of Evaluation in Clinical Practice. 22:235-246
Rationales, aims and objectives The increasing dispensing of statins has raised concern about the appropriateness of prescribing to various population groups. We aimed to (1) investigate incident and prevalent statin prescribing according to indicati
Publikováno v:
European Journal of Clinical Pharmacology. 71:1245-1254
Ezetimibe is used as a second-line lipid-lowering medication (LLM) if statin therapy is not tolerated or cholesterol targets are not reached by statins alone. We aimed to investigate the impact of sociodemographic factors on ezetimibe initiation as (
Publikováno v:
Health Promotion International. 31:635-643
Salutogenic orientation is a health promotion paradigm focusing on the resources of the individual. This study analyzed the relationship between sense of coherence (SOC) and self-efficacy (SE) based on population data. By conducting an empirical anal
Autor:
Peter Bjødstrup Jensen, Lise Aagaard, Pernille Warrer, Henrik U. Andersen, Malene Hammer Krag, Søren Brunak, Peter Rossing, Thomas Almdal, Ebba Holme Hansen, Lars Juhl Jensen
Publikováno v:
Journal of Research in Pharmacy Practice
Warrer, P, Jensen, P B, Aagaard, L, Jensen, L J, Brunak, S, Krag, M H, Rossing, P, Almdal, T, Andersen, H U & Hansen, E H 2015, ' Identification of possible adverse drug reactions in clinical notes : the case of glucose-lowering medicines ' Journal of Research in Pharmacy Practice, vol. 4, no. 2, pp. 64-72 . https://doi.org/10.4103/2279-042X.155753
Warrer, P, Jensen, P B, Aagaard, L, Jensen, L J, Brunak, S, Krag, M, Rossing, P, Almdal, T, Andersen, H U & Hansen, E H 2015, ' Identification of possible adverse drug reactions in clinical notes : the case of glucose-lowering medicines ', Journal of Research in Pharmacy Practice, vol. 4, no. 2, pp. 64-72 . https://doi.org/10.4103/2279-042X.155753
Journal of Research in Pharmacy Practice, Vol 4, Iss 2, Pp 64-72 (2015)
Warrer, P, Jensen, P B, Aagaard, L, Jensen, L J, Brunak, S, Krag, M H, Rossing, P, Almdal, T, Andersen, H U & Hansen, E H 2015, ' Identification of possible adverse drug reactions in clinical notes : the case of glucose-lowering medicines ' Journal of Research in Pharmacy Practice, vol. 4, no. 2, pp. 64-72 . https://doi.org/10.4103/2279-042X.155753
Warrer, P, Jensen, P B, Aagaard, L, Jensen, L J, Brunak, S, Krag, M, Rossing, P, Almdal, T, Andersen, H U & Hansen, E H 2015, ' Identification of possible adverse drug reactions in clinical notes : the case of glucose-lowering medicines ', Journal of Research in Pharmacy Practice, vol. 4, no. 2, pp. 64-72 . https://doi.org/10.4103/2279-042X.155753
Journal of Research in Pharmacy Practice, Vol 4, Iss 2, Pp 64-72 (2015)
Objective: Through manual review of clinical notes for patients with type 2 diabetes mellitus attending a Danish diabetes center, the aim of the study was to identify adverse drug reactions (ADRs) associated with three classes of glucose-lowering med